ImmunityBio, Inc. (IBRX) News
Track canonical SquawkNews coverage tagged to IBRX, ImmunityBio, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 8 indexed stories across 7 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
SLS, IBRX In Focus: Canadian Insurance Giant Manulife’s Unit Raises Stakes Ahead Of Key Cancer Catalysts
Sellas Life Sciences (SLS) and ImmunityBio (IBRX) drew attention on Wednesday after Canadian insurance giant Manulife’s principal operating insurer disclosed that it increased its institutional stakes in both cancer-drug
EQUITY | Sep 10, 2026, 03:04 AM UTC
M
IBRX rises on cancer vaccine trial milestone update
IBRX shares are heading for their best week in over two months after a cancer vaccine trial milestone update tied to Chairman Soon Shiong.
EQUITY | Aug 27, 2026, 05:57 PM UTC
L
SLS, IBRX Eye Fresh Oncology Tailwind As Cathie Wood’s ARK Backs Personalized Cancer-Vaccine Future
SLS, IBRX Eye Fresh Oncology Tailwind As Cathie Wood’s ARK Backs Personalized Cancer-Vaccine Future
EQUITY | Aug 27, 2026, 07:10 AM UTC
L
SLS, IBRX Catch The Eye Of A Major US Pension Fund — And Big Clinical Catalysts Are On The Horizon
SLS, IBRX Catch The Eye Of A Major US Pension Fund — And Big Clinical Catalysts Are On The Horizon
EQUITY | Aug 26, 2026, 08:12 AM UTC
H
IBRX Reports Record Q2 Revenue Up 92%
IBRX Q2 revenue rises 92% year-over-year
EQUITY | Aug 04, 2026, 11:32 AM UTC
H
Immunitybio Receives UAE Marketing Authorization
Immunitybio gets UAE approval for ANKTIVA
EQUITY | Jul 30, 2026, 12:57 AM UTC
H
UAE Approves ImmunityBio's ANKTIVA
UAE grants marketing authorization for ANKTIVA
EQUITY | Jul 29, 2026, 10:50 PM UTC
L
ImmunityBio Insider Sold Shares Worth $1,439,066, According to a Recent SEC Filing
() -- Christobel Selecky, Director, on July 01, 2026, sold 159,478 shares in ImmunityBio (IBRX) for $1,439,066. SEC Filing: Copyright © 2026. All rights reserved. does not provide investment advice. Unauthorized reproduc
REGULATION | Jul 07, 2026, 07:49 AM UTC